Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia During the Influenza Season (U18).

Trial Profile

Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia During the Influenza Season (U18).

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Oseltamivir (Primary) ; Antibacterials; Antivirals; Zanamivir
  • Indications Bacterial infections; Community-acquired pneumonia; Influenza virus infections; Respiratory tract infections
  • Focus Therapeutic Use
  • Acronyms RETOS
  • Most Recent Events

    • 18 Oct 2016 Status changed from recruiting to completed.
    • 13 Nov 2012 Planned end date changed from 1 May 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 06 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top